Related Experiment Video
Updated: Jun 23, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Adrenoceptors and Hypertension
Spoorthy Kulkarni1, Ian B Wilkinson2
1Department of Experimental Medicine and Immunotherapeutics, Vascular Research Clinic, ACCI Level 3, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Hypertension, a common condition, involves blood vessel changes and end-organ damage. Early stages show hemodynamic shifts and kidney issues, with adrenoceptor stimulation and the renin-angiotensin-aldosterone system playing key roles.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Pharmacology
Background:
- Hypertension is a prevalent condition causing significant mortality and morbidity due to vascular and end-organ damage.
- Early hypertension stages, particularly in young men, involve hemodynamic alterations like increased cardiac output and peripheral resistance.
- Kidney damage from increased sodium reabsorption is a proposed initial trigger for essential hypertension.
Purpose of the Study:
- To review the pathophysiological mechanisms of hypertension, focusing on adrenoceptor stimulation and the renin-angiotensin-aldosterone system.
- To discuss the historical and current therapeutic roles of adrenoceptor antagonists and other antihypertensive agents.
- To highlight hypertension management in specific complex medical conditions.
Main Methods:
- Review of pathophysiological mechanisms including catecholamine effects on adrenoceptors and the renin-angiotensin-aldosterone system.
- Analysis of the therapeutic evolution of antihypertensive drugs, from early adrenoceptor blockers to current first-line agents.
- Examination of hypertension in specific conditions like pregnancy, phaeochromocytoma, and pulmonary arterial hypertension.
Main Results:
- Adrenoceptor stimulation (α1, β1) and renin-angiotensin-aldosterone system activation contribute to endothelial dysfunction and persistent hypertension.
- While initially used, α1 blockers, α2 agonists, and β blockers are no longer first-line due to outcome trial results.
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, and thiazide-like diuretics are now considered first-line therapies.
Conclusions:
- Adrenoceptor agents remain relevant as second- or third-line therapy for hypertension.
- Understanding adrenoceptor roles is crucial for managing hypertension in various clinical contexts.
- This overview provides insights for clinicians and researchers on adrenoceptors in hypertension pathophysiology and treatment.
Related Concept Videos
Antihypertensive Drugs: Action of β1 Blockers
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

